KESTREL

Clinical Trials // Diabetic Macular Edema // Michael Altaweel // Past // Jun 12 2019

A Two-year, Three-arm, Randomized, Double-masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients with Visual Impairment Due to Diabetic Macular Edema (KESTREL)


SPONSOR: Novartis Pharmaceuticals

CLINICALTRIALS.GOVĀ